{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:27Z","timestamp":1792787847409,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82305411"],"award-info":[{"award-number":["82305411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82430124"],"award-info":[{"award-number":["82430124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["2023MD744131"],"award-info":[{"award-number":["2023MD744131"]}]},{"name":"the Department of Science and Technology of Sichuan Province","award":["2023NSFSC1822"],"award-info":[{"award-number":["2023NSFSC1822"]}]},{"name":"the Department of Science and Technology of Sichuan Province","award":["24NSFSC0097"],"award-info":[{"award-number":["24NSFSC0097"]}]},{"name":"Chengdu University of TCM\u2014Affiliated Hospital Joint Innovation Fund","award":["LH202402012"],"award-info":[{"award-number":["LH202402012"]}]},{"name":"the National Clinical Medical Research Center of Chinese Medicine and Acupuncture","award":["NCRCOP2023001"],"award-info":[{"award-number":["NCRCOP2023001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-05217-5","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T22:37:52Z","timestamp":1752791872000},"page":"14227-14244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Disrupted Lipid Metabolism Aggravates Ischemic Brain Injury: Targeting FDFT1 for Stroke Therapy"],"prefix":"10.1007","volume":"62","author":[{"given":"Jing","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sha","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Min","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Long","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"5217_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMcp1917030","volume":"383","author":"WJ Powers","year":"2020","unstructured":"Powers WJ (2020) Acute ischemic stroke. N Engl J Med 383:252\u2013260","journal-title":"N Engl J Med"},{"key":"5217_CR2","doi-asserted-by":"crossref","unstructured":"GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20:795\u2013820","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"5217_CR3","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1212\/WNL.0000000000207387","volume":"101","author":"J Fan","year":"2023","unstructured":"Fan J et al (2023) Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990\u20132030. Neurology 101:e137\u2013e150","journal-title":"Neurology"},{"key":"5217_CR4","doi-asserted-by":"crossref","unstructured":"Yang P, Zhang Y, Liu J (2025) Ischaemic stroke in 2024: progress on multiple fronts. Lancet. Neurol 24(1):7-8","DOI":"10.1016\/S1474-4422(24)00473-3"},{"key":"5217_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1161\/CIRCRESAHA.116.309278","volume":"120","author":"L Catanese","year":"2017","unstructured":"Catanese L, Tarsia J, Fisher M (2017) Acute ischemic stroke therapy overview. Circ Res 120:541\u2013558","journal-title":"Circ Res"},{"key":"5217_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/STROKEAHA.122.040524","volume":"54","author":"MS Ekker","year":"2023","unstructured":"Ekker MS et al (2023) Risk factors and causes of ischemic stroke in 1322 young adults. Stroke 54:439\u2013447","journal-title":"Stroke"},{"key":"5217_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jare.2023.08.007","volume":"61","author":"X-X Huang","year":"2024","unstructured":"Huang X-X et al (2024) Lipidomic analysis identifies long-chain acylcarnitine as a target for ischemic stroke. J Adv Res 61:133\u2013149","journal-title":"J Adv Res"},{"key":"5217_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106482","volume":"185","author":"Y Ma","year":"2022","unstructured":"Ma Y et al (2022) Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy. Pharmacol Res 185:106482","journal-title":"Pharmacol Res"},{"key":"5217_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166149","volume":"134","author":"S Xu","year":"2024","unstructured":"Xu S et al (2024) TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase. J Clin Invest 134:e166149","journal-title":"J Clin Invest"},{"key":"5217_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J et al (2021) Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events. Stroke 52:103\u2013110","journal-title":"Stroke"},{"key":"5217_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C (2016) Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 65:589\u2013600","journal-title":"J Hepatol"},{"key":"5217_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016) Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 118:535\u2013546","journal-title":"Circ Res"},{"key":"5217_CR13","doi-asserted-by":"publisher","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","volume":"8","author":"K Malekmohammad","year":"2021","unstructured":"Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M (2021) Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms. Front Cardiovasc Med 8:707529","journal-title":"Front Cardiovasc Med"},{"key":"5217_CR14","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673348217241119063941","author":"MA Akram","year":"2025","unstructured":"Akram MA, Khodja A, Dalibalta S, Majdalawieh AF (2025) The role of lipids in atherosclerosis: focus on molecular biology mechanisms and therapeutic approaches. Curr Med Chem. https:\/\/doi.org\/10.2174\/0109298673348217241119063941","journal-title":"Curr Med Chem"},{"key":"5217_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.105.593418","volume":"114","author":"I Kronzon","year":"2006","unstructured":"Kronzon I, Tunick PA (2006) Aortic atherosclerotic disease and stroke. Circulation 114:63\u201375","journal-title":"Circulation"},{"key":"5217_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"5217_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab554","volume":"49","author":"K Tang","year":"2021","unstructured":"Tang K et al (2021) Rank-in: enabling integrative analysis across microarray and RNA-seq for cancer. Nucleic Acids Res 49:e99","journal-title":"Nucleic Acids Res"},{"key":"5217_CR18","doi-asserted-by":"crossref","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation Cambridge Mass 2(3):100141","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"5217_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"5217_CR20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"R Me","year":"2015","unstructured":"Me R et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids Res 43(7):e47","journal-title":"Nucleic acids Res"},{"issue":"7","key":"5217_CR21","doi-asserted-by":"publisher","first-page":"e1003731","DOI":"10.1371\/journal.pcbi.1003731","volume":"10","author":"R Janky","year":"2014","unstructured":"Janky R et al (2014) iRegulon: from a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol 10(7):e1003731","journal-title":"PLoS Comput Biol"},{"key":"5217_CR22","doi-asserted-by":"crossref","unstructured":"R Y et al (2014) The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic acids research 42:e133","DOI":"10.1093\/nar\/gku631"},{"key":"5217_CR23","doi-asserted-by":"publisher","unstructured":"Yuan J et al (2024) Integrating bulk RNA and single-cell sequencing data unveils efferocytosis patterns and ceRNA network in ischemic stroke. Transl Stroke Res 16:733-746. https:\/\/doi.org\/10.1007\/s12975-024-01255-8","DOI":"10.1007\/s12975-024-01255-8"},{"key":"5217_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep38062","volume":"6","author":"H Kurinami","year":"2016","unstructured":"Kurinami H et al (2016) A novel therapeutic peptide as a partial agonist of RANKL in ischemic stroke. Sci Rep 6:38062","journal-title":"Sci Rep"},{"key":"5217_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/STROKEAHA.120.030285","volume":"52","author":"MF Pengo","year":"2021","unstructured":"Pengo MF et al (2021) Impact of sleep apnea on cardioembolic risk in patients with atrial fibrillation: data from the ESADA cohort. Stroke 52:712\u2013715","journal-title":"Stroke"},{"key":"5217_CR26","doi-asserted-by":"crossref","unstructured":"W S et al (2019) Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 18:394-405","DOI":"10.1016\/S1474-4422(18)30500-3"},{"issue":"2","key":"5217_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5009\/gnl19069","volume":"14","author":"AA Li","year":"2020","unstructured":"Li AA, Ahmed A, Kim D (2020) Extrahepatic manifestations of nonalcoholic fatty liver disease. Gut Liver 14(2):168\u2013178","journal-title":"Gut Liver"},{"key":"5217_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","volume":"116","author":"P Libby","year":"2015","unstructured":"Libby P, Hansson GK (2015) Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res 116:307\u2013311","journal-title":"Circ Res"},{"key":"5217_CR29","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.2337\/dc07-0349","volume":"30","author":"G Targher","year":"2007","unstructured":"Targher G et al (2007) Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 30:2119\u20132121","journal-title":"Diabetes Care"},{"key":"5217_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","volume":"71","author":"MV Holmes","year":"2018","unstructured":"Holmes MV et al (2018) Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol 71:620\u2013632","journal-title":"J Am Coll Cardiol"},{"key":"5217_CR31","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","volume":"365","author":"SJ Nicholls","year":"2011","unstructured":"Nicholls SJ et al (2011) Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 365:2078\u20132087","journal-title":"N Engl J Med"},{"key":"5217_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco P et al (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355:549\u2013559","journal-title":"N Engl J Med"},{"key":"5217_CR33","doi-asserted-by":"crossref","unstructured":"Aradine E, Hou Y, Cronin CA, Chaturvedi S (2020) Current status of dyslipidemia treatment for stroke prevention. Curr Neurol Neurosci Rep 20(8):31","DOI":"10.1007\/s11910-020-01052-4"},{"key":"5217_CR34","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN et al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45:2160\u20132236","journal-title":"Stroke"},{"key":"5217_CR35","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP et al (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387\u20132397","journal-title":"N Engl J Med"},{"key":"5217_CR36","doi-asserted-by":"crossref","unstructured":"Dg H, Ra H (2022) Lipid-modifying therapies and stroke prevention.Curr Neurol Neurosci Rep 22:375-382","DOI":"10.1007\/s11910-022-01197-4"},{"key":"5217_CR37","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","volume":"72","author":"RS Rosenson","year":"2018","unstructured":"Rosenson RS, Hegele RA, Fazio S, Cannon CP (2018) The evolving future of PCSK9 inhibitors. J Am Coll Cardiol 72:314\u2013329","journal-title":"J Am Coll Cardiol"},{"key":"5217_CR38","doi-asserted-by":"crossref","unstructured":"Hegele RA, Tsimikas S (2019) Lipid-lowering agents. Circ Res 124(3):386\u2013404","DOI":"10.1161\/CIRCRESAHA.118.313171"},{"key":"5217_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamaneurol.2023.5716","volume":"81","author":"Y Fu","year":"2024","unstructured":"Fu Y et al (2024) Sublingual edaravone dexborneol for the treatment of acute ischemic stroke: the TASTE-SL randomized clinical trial. JAMA Neurol 81:319\u2013326","journal-title":"JAMA Neurol"},{"key":"5217_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/STROKEAHA.107.486654","volume":"39","author":"T Nakamura","year":"2008","unstructured":"Nakamura T et al (2008) Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke 39:463\u2013469","journal-title":"Stroke"},{"key":"5217_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109315","volume":"113","author":"R Hu","year":"2022","unstructured":"Hu R et al (2022) Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke. Int Immunopharmacol 113:109315","journal-title":"Int Immunopharmacol"},{"key":"5217_CR42","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.0000182241.07096.06","volume":"36","author":"N Zhang","year":"2005","unstructured":"Zhang N et al (2005) Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36:2220\u20132225","journal-title":"Stroke"},{"key":"5217_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106865","volume":"88","author":"X Dong","year":"2020","unstructured":"Dong X et al (2020) Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT\/mTOR\/SREBP-2 pathway. Int Immunopharmacol 88:106865","journal-title":"Int Immunopharmacol"},{"key":"5217_CR44","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41419-019-1858-9","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H et al (2019) Deletion of OSBPL2 in auditory cells increases cholesterol biosynthesis and drives reactive oxygen species production by inhibiting AMPK activity. Cell Death Dis 10:627","journal-title":"Cell Death Dis"},{"key":"5217_CR45","doi-asserted-by":"crossref","unstructured":"Zhou T et al (2023) Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism. PeerJ 11:e15225","DOI":"10.7717\/peerj.15225"},{"key":"5217_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell 146:353\u2013358","journal-title":"Cell"},{"key":"5217_CR47","doi-asserted-by":"publisher","first-page":"8432352","DOI":"10.1155\/2022\/8432352","volume":"2022","author":"J Fan","year":"2022","unstructured":"Fan J et al (2022) Investigating the AC079305\/DUSP1 axis as oxidative stress-related signatures and immune infiltration characteristics in ischemic stroke. Oxid Med Cell Longevity 2022:8432352","journal-title":"Oxid Med Cell Longevity"},{"key":"5217_CR48","doi-asserted-by":"publisher","first-page":"26265","DOI":"10.1364\/OE.22.026265","volume":"22","author":"A Ritter","year":"2014","unstructured":"Ritter A (2014) Modified shifted angular spectrum method for numerical propagation at reduced spatial sampling rates. Opt Express 22:26265\u201326276","journal-title":"Opt Express"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05217-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:33:59Z","timestamp":1759995239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5217"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05217-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Committee on Ethical Use of Animals of Chengdu University of Traditional Chinese Medicine (NO. 2023DL-022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}